A phase I–II study of rituximab, ifosfamide, mitoxantrone andetoposide (R-IME) for B cell non-Hodgkin’s lymphoma prior to and after high-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT)
| Autor: | Joyce, R.M. *, Regan, M., Ottaway, J., Umiel, T., Tetreault, J.-C., Levine, J., McDermott, D., Hurley, D., Giallombardo, N., Smith, T., Lamontagne, D., Uhl, L., Avigan, D. |
|---|---|
| Zdroj: | In Annals of Oncology May 2003 14 Supplement 1:i21-i27 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|